Disease/Infection News

RSS

Fluctuating blood pressure may be a hidden culprit in dementia risk for seniors

Australian researchers find that fluctuating blood pressure, not just high levels, is associated with an increased risk of dementia and vascular issues in older adults. The study suggests that blood pressure variability could be an early marker for cognitive impairment, opening new avenues for treatment.

17 Oct 2023

Acinetobacter baumannii can fall into a deep sleep to survive harsh conditions

A research team led by Beate Averhoff and Volker Müller of Goethe University Frankfurt has discovered a fundamental mechanism that helps the dreaded hospital pathogen Acinetobacter baumannii to survive.

16 Oct 2023

Lab-grown skin organoids help scientists understand monkeypox infection

Skin organoids offer a powerful platform for drug discovery in the ongoing fight against the virus formerly known as monkeypox.

16 Oct 2023

UNLV scientists discover way to interfere with virulence protein in Shigella

The legendary Alexander Fleming, who famously discovered penicillin, once said "never to neglect an extraordinary appearance or happening."

16 Oct 2023

Antibiotic-resistant bacteria in Ghana confined to clinical settings

Calland, J. K., et al. (2023). Population structure and antimicrobial resistance among Klebsiella isolates sampled from human, animal, and environmental sources in Ghana: a cross-sectional genomic One Health study. The Lancet Microbe. doi.org/10.1016/S2666-5247(23)00208-2.

16 Oct 2023

Paxlovid treatment provides protection against COVID-19 for both mother and child

A new mouse model of infection with the COVID-19-causing SARS-CoV-2 virus during pregnancy tracks closely the disease course doctors have observed in SARS-CoV-2-infected pregnant patients, and suggests that treatment with the antiviral Paxlovid provides protection for both mother and child.

16 Oct 2023

Researchers discover nuanced insights from COVID-19's impact on mortality rates

A multi-institutional team of researchers led by the White River Junction VA, and including the West Haven and Palo Alto VA, analyzed electronic health record data from more than 5.9 million Veterans-spanning both pre-pandemic (March 2018 - February 2020) and pandemic (March 2020 - February 2022) periods-to discover nuanced insights from COVID-19's impact on mortality rates.

16 Oct 2023

Study links long COVID to gut inflammation and serotonin deficiency

Patients with long COVID – the long-term symptoms like brain fog, fatigue, or memory loss in the months or years following COVID-19 – can exhibit a reduction in circulating levels of the neurotransmitter serotonin, according to new research published today in Cell.

16 Oct 2023

Study reveals previously unappreciated role for innate immune cells in early stages of TB infection

A new study from the University of Pittsburgh Center for Vaccine Research published today in the Journal of Experimental Medicine describes a previously unappreciated role for a class of immune cells in the early stages of tuberculosis (TB) infection.

16 Oct 2023

Antiverse and GlobalBio, Inc. extend collaboration to advance antibody cancer therapeutics

Antiverse Ltd (Antiverse) and GlobalBio, Inc. (GlobalBio) today announced they will be extending their collaboration to advance immune checkpoint inhibitors in cancer therapy.

From Antiverse 16 Oct 2023

Study shows widespread prevalence of dangerous pathogens in ventilated patients

University of Maryland School of Medicine (UMSOM) researchers conducted a statewide survey of all patients on breathing machines in hospitals and long-term care facilities and found that a significant percentage of them harbored two pathogens known to be life-threatening in those with compromised immune systems.

15 Oct 2023

New mRNA flu vaccine shows promise: Faster to produce, highly effective in mice

The study evaluates the efficacy of a new quadrivalent mRNA influenza vaccine, finding it to be highly immunogenic and protective in a mouse model. Compared to traditional vaccines, the mRNA-based option offers advantages like reduced production time and elimination of the risk of growth-promoting mutations.

15 Oct 2023

Is it time to rethink COVID-19 boosters? New study dives into variant-specific vaccines

The study explores the efficacy of variant-adapted COVID-19 booster vaccines, particularly against new strains like Omicron. It raises questions about the need for annual updates and the best technologies for long-term, durable immunity.

15 Oct 2023

Early and severe: Kids hit hard by 2022-23 flu season, vaccination rates drop

The 2022-23 influenza season saw a highly severe impact on U.S. adolescents and children, with early peaks in hospitalization rates and outpatient visits. The study underscores the importance of flu vaccination and antiviral treatment, especially as fewer hospitalized children were vaccinated compared to previous seasons.

15 Oct 2023

New TB treatments tackle the disease without wrecking your microbiome

Researchers in a study published in The Lancet Microbe examined how various tuberculosis treatment regimens affect the respiratory microbiome. They found that certain treatments control tuberculosis effectively while minimally impacting the diversity and health of the respiratory microbiome.

15 Oct 2023

Are people with HIV at a higher risk of severe COVID-19 outcomes?

The research review indicates that people with HIV, especially those with low CD4 cell counts, face greater risks of severe COVID-19 outcomes and have suboptimal immune responses to SARS-CoV-2. Antiretroviral therapy aids in clearing infections, and a third vaccine dose reduces the risk of breakthrough infections among this population.

15 Oct 2023

Long-term lung issues and lower quality of life plague COVID-19 survivors, new study warns

New research in Scientific Reports reveals that COVID-19 survivors, especially those who had severe or critical illness, face long-term lung complications and a reduced quality of life. The study recommends 6-monthly pulmonary function tests for these survivors to monitor for chronic lung damage.

15 Oct 2023

Pfizer Australia and BioNTech announce TGA approval for Omicron XBB.1.5-adapted monovalent COVID-19 vaccine

Pfizer Australia and BioNTech SE today announced that the Therapeutic Goods Administration (TGA) have authorised the companies’ XBB.1.5-adapted monovalent COVID-19 vaccine (COMIRNATY® Omicron XBB.1.5) in individuals 5 years and older.

14 Oct 2023

Gates Foundation announces investments to advance mRNA vaccine research and manufacturing

At the 2023 Grand Challenges Annual Meeting, Bill Gates, Co-chair of the Bill & Melinda Gates Foundation, announced new investments to advance access to mRNA research and vaccine manufacturing technology that will support low- and middle-income countries’ (LMICs) capacity to develop high-quality, lifesaving vaccines at scale.

14 Oct 2023

Study identifies significant percentage of ventilated patients colonized with life-threatening pathogens

13 Oct 2023

Disease/Infection News

Fluctuating blood pressure may be a hidden culprit in dementia risk for seniors

Acinetobacter baumannii can fall into a deep sleep to survive harsh conditions

Lab-grown skin organoids help scientists understand monkeypox infection

UNLV scientists discover way to interfere with virulence protein in Shigella

Antibiotic-resistant bacteria in Ghana confined to clinical settings

Paxlovid treatment provides protection against COVID-19 for both mother and child

Researchers discover nuanced insights from COVID-19's impact on mortality rates

Study links long COVID to gut inflammation and serotonin deficiency

Study reveals previously unappreciated role for innate immune cells in early stages of TB infection

Antiverse and GlobalBio, Inc. extend collaboration to advance antibody cancer therapeutics

Study shows widespread prevalence of dangerous pathogens in ventilated patients

New mRNA flu vaccine shows promise: Faster to produce, highly effective in mice

Is it time to rethink COVID-19 boosters? New study dives into variant-specific vaccines

Early and severe: Kids hit hard by 2022-23 flu season, vaccination rates drop

New TB treatments tackle the disease without wrecking your microbiome

Are people with HIV at a higher risk of severe COVID-19 outcomes?

Long-term lung issues and lower quality of life plague COVID-19 survivors, new study warns

Pfizer Australia and BioNTech announce TGA approval for Omicron XBB.1.5-adapted monovalent COVID-19 vaccine

Gates Foundation announces investments to advance mRNA vaccine research and manufacturing

Study identifies significant percentage of ventilated patients colonized with life-threatening pathogens

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News